PVLA insider filings

PALVELLA THERAPEUTICS, INC. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-11-12. Screen PVLA transaction legs live →

Insider transaction summary — last 90 days

2026-08-23 to 2026-11-21, from the filings listed below: 6 insider filings (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By insider — same window

Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

InsiderFilingsPurchases (P)Sales (S)Other legs
JENKINS GEORGE M — Director2—26 legs · 55,000 sh · $7,746,622—
Martini Jeffrey S — Chief Scientific Officer1—13 legs · 12,500 sh · $2,083,0766
Goin Kathleen — Chief Operating Officer2—6 legs · 8,615 sh · $1,192,2308
KIRITSY CHRISTOPHER P — Director1—1 leg · 313 sh · $49,1412

Recent insider filings — PALVELLA THERAPEUTICS, INC.

FiledFormInsiderReported transactionsSource
2026-11-124Martini Jeffrey S — Chief Scientific OfficerOption exercise (M): 4,266 @ $7.53 · Option exercise (M): 1,984 @ $9.79 · Sale (S): 100 @ $163.34 · Sale (S): 1,449 @ $164.85 · Sale (S): 1,651 @ $165.85 · Sale (S): 1,500 @ $166.91 · +13 moreEDGAR
2026-10-234Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,165 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 2,043 @ $123.62 · Sale (S): 1,663 @ $125.16 · Sale (S): 607 @ $126.19 · Option exercise (M): 2,165 (derivative) @ $0 · +1 moreEDGAR
2026-10-144JENKINS GEORGE M — DirectorSale (S): 5,095 @ $132.62 · Sale (S): 2,458 @ $133.25 · Sale (S): 3,335 @ $134.21 · Sale (S): 1,447 @ $135.50 · Sale (S): 817 @ $136.44 · Sale (S): 2,004 @ $128.52 · +11 moreEDGAR
2026-09-184Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,659 @ $151.16 · Sale (S): 989 @ $152.36 · Sale (S): 1,654 @ $153.24 · Option exercise (M): 2,154 (derivative) @ $0 · +1 moreEDGAR
2026-09-154JENKINS GEORGE M — DirectorSale (S): 6,520 @ $150.62 · Sale (S): 4,577 @ $151.72 · Sale (S): 1,274 @ $153.06 · Sale (S): 5,632 @ $151.46 · Sale (S): 6,160 @ $152.12 · Sale (S): 1,560 @ $153.10 · +3 moreEDGAR
2026-09-044KIRITSY CHRISTOPHER P — DirectorOption exercise (M): 313 @ $127.20 · Sale (S): 313 @ $157 · Option exercise (M): 313 (derivative) @ $0EDGAR
2026-08-204Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,500 @ $151.39 · Sale (S): 1,998 @ $151.80 · Sale (S): 400 @ $153.00 · Sale (S): 102 @ $155.59 · +3 moreEDGAR
2026-07-174Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 522 @ $147.14 · Sale (S): 840 @ $148.40 · Sale (S): 1,029 @ $149.27 · Sale (S): 1,911 @ $150.25 · +2 moreEDGAR
2026-07-014Pauls Matthew — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2026-06-224Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 2,390 @ $110.26 · Sale (S): 1,887 @ $111.31 · Sale (S): 25 @ $112.23 · Option exercise (M): 2,154 (derivative) @ $0 · +1 moreEDGAR
2026-06-164Korenberg Matthew E — CFO, TreasurerOption exercise (M): 1,000 @ $13.60 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2026-06-124Doux John — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-06-124Wessel Tadd S. — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-06-124Davis Todd C — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-06-124JENKINS GEORGE M — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-06-124KIRITSY CHRISTOPHER P — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-06-124HERON ELAINE J — DirectorGrant/award (A): 3,000 (derivative) @ $0EDGAR
2026-05-224Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 3,363 @ $110.35 · Sale (S): 891 @ $111.30 · Sale (S): 48 @ $111.89 · Option exercise (M): 2,154 (derivative) @ $0 · +1 moreEDGAR
2026-04-174Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,502 @ $125.96 · Sale (S): 1,500 @ $127.13 · Sale (S): 561 @ $128.23 · Sale (S): 639 @ $129.17 · +3 moreEDGAR
2026-04-154Doux John — DirectorGrant/award (A): 6,000 (derivative) @ $0EDGAR
2026-04-014JENKINS GEORGE M — DirectorPurchase (P): 445 @ $112.30EDGAR
2026-03-204Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 2,268 @ $117.56 · Sale (S): 1,730 @ $118.37 · Sale (S): 304 @ $119.08 · Option exercise (M): 2,154 (derivative) @ $0 · +1 moreEDGAR
2026-03-024JENKINS GEORGE M — DirectorPurchase (P): 4,000 @ $125EDGAR
2026-03-024HERON ELAINE J — DirectorPurchase (P): 2,400 @ $125EDGAR
2026-02-204Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 3,026 @ $79.16 · Sale (S): 1,276 @ $79.97 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0EDGAR
2026-02-094Martini Jeffrey S — Chief Scientific OfficerGrant/award (A): 64,318 (derivative) @ $0EDGAR
2026-02-094Kline Ashley Hartmann — Chief Commercial OfficerGrant/award (A): 38,517 (derivative) @ $0EDGAR
2026-02-094Kaupinen Wes — President and CEO, Director, 10% ownerGrant/award (A): 124,603 (derivative) @ $0EDGAR
2026-02-094Korenberg Matthew E — CFO, TreasurerGrant/award (A): 44,123 (derivative) @ $0EDGAR
2026-02-094Goin Kathleen — Chief Operating OfficerGrant/award (A): 48,956 (derivative) @ $0EDGAR
2026-01-234Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 553 @ $95.49 · Sale (S): 3,749 @ $97.94 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0EDGAR
2025-12-194Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 4,302 @ $96.47 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0EDGAR
2025-11-214Goin Kathleen — Chief Operating OfficerOption exercise (M): 2,154 @ $7.14 · Option exercise (M): 2,148 @ $9.08 · Sale (S): 1,500 @ $85.72 · Sale (S): 2,802 @ $86.51 · Option exercise (M): 2,154 (derivative) @ $0 · Option exercise (M): 2,148 (derivative) @ $0EDGAR
2025-06-114Wessel Tadd S. — DirectorGrant/award (A): 12,350 (derivative) @ $0EDGAR
2025-06-114Davis Todd C — DirectorGrant/award (A): 12,350 (derivative) @ $0EDGAR
2025-06-114JENKINS GEORGE M — DirectorGrant/award (A): 12,350 (derivative) @ $0EDGAR
2025-06-114KIRITSY CHRISTOPHER P — DirectorGrant/award (A): 12,350 (derivative) @ $0EDGAR
2025-06-114HERON ELAINE J — DirectorGrant/award (A): 12,350 (derivative) @ $0EDGAR
2025-06-034Kline Ashley Hartmann — Chief Commercial OfficerGrant/award (A): 17,436 (derivative) @ $0 · Grant/award (A): 111,496 (derivative) @ $0EDGAR
2025-04-104JENKINS GEORGE M — DirectorPurchase (P): 2,500 @ $20.13 · Purchase (P): 2,490 @ $20.27EDGAR
2025-02-104/AKaupinen Wes — President and CEO, DirectorGrant/award (A): 243,831 (derivative) @ $0EDGAR
2025-02-104/AMartini Jeffrey S — Chief Scientific OfficerGrant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2025-02-104/AGoin Kathleen — Chief Operating OfficerGrant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2025-02-104/AKorenberg Matthew E — CFO and TreasurerGrant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2025-02-074PALVELLA THERAPEUTICS, INC. — Chief Scientific OfficerGrant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2025-02-074PALVELLA THERAPEUTICS, INC. — CFO and TreasurerGrant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2025-02-074PALVELLA THERAPEUTICS, INC. — President and CEO, DirectorGrant/award (A): 243,831 (derivative) @ $0EDGAR
2025-02-074PALVELLA THERAPEUTICS, INC. — Chief Operating OfficerGrant/award (A): 5,373 (derivative) @ $0 · Grant/award (A): 123,559 (derivative) @ $0EDGAR
2024-12-194JENKINS GEORGE M — DirectorPurchase (P): 4,000 @ $12.93EDGAR
2024-12-174BVF PARTNERS L P/IL
BIOTECHNOLOGY VALUE FUND L P
BVF I GP LLC
BIOTECHNOLOGY VALUE FUND II LP
BVF II GP LLC
Biotechnology Value Trading Fund OS LP
BVF Partners OS Ltd.
BVF GP HOLDINGS LLC
BVF INC/IL
LAMPERT MARK N
Other (J): 234,323 · Other (J): 174,958 · Other (J): 29,648EDGAR

Recent 8-K events — PALVELLA THERAPEUTICS, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-198-K7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-11-058-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-288-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-048-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-148-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-308-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-06-168-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-208-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-158-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-138-K8.01 — Other EventsEDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PVLA returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs